Research Article

Epidemiological and Clinical Characteristics of Hospitalized Pediatric Patients with SARS-CoV-2 Infection in Mexico City, Mexico

Table 1

Comparison of demographics, clinical features, comorbidities, and hematological parameters between SARS-CoV-2 positive and negative pediatric patients.

VariableSARS-CoV-2 positive, n = 36SARS-CoV-2 negative, n = 85value

Demographics
Sex (male)16 (44.4%)49 (57.6%)0.1
Age (years)
 <512 (33.3%)43 (56.6%)0.006
 6 to 106 (16.7%)17 (20.0%)
 11 to 1516 (44.4%)13 (15.3%)
 15 to 172 (5.6%)12 (14.1%)
Contact with a confirmed case8 (22.2%)6 (7.1%)0.01

Clinical features
Hospitalization (>1 day)17 (47.2%)38 (44.7%)0.7
Comorbidities
 Asthma3 (8.3%)4 (4.7%)0.4
 Immunosuppression5 (13.9%)15 (17.6%)0.6
 Cancer5 (13.9%)24 (28.2%)0.09
 Hypertension1 (2.8%)1 (1.2%)0.5
 Obesity5 (13.9%)3 (3.5%)0.03
 Allergies3 (8.3%)9 (10.6%)0.7
CO-RADSn = 14n = 14
 11 (7.1%)8 (57.1%)0.003
 22 (14.3%)0 (0.0%)
 31 (7.1%)0 (0.0%)
 40 (0.0%)2 (14.3%)
 510 (71.4%)4 (28.6%)
Completed vaccination schemen = 15n = 37
 No0 (0.0%)8 (21.6%)0.1
 Incomplete4 (26.7%)9 (24.3%)
 Complete11 (73.3%)20 (54.1%)

Hematological parameters
ABO blood groupn = 13n = 24
 O9 (69.2%)18 (75.0%)0.9
 A2 (15.4%)3 (12.5%)
 B2 (15.4%)3 (12.5%)
Lymphocytesn = 18n = 45
 Normal4 (22.2%)13 (28.9%)0.6
 Low13 (72.2%)27 (60.0%)
 Hight1 (5.6%)5 (11.1%)
Leukocytesn = 18n = 45
 Normal9 (50.0%)14 (31.1%)0.3
 Low7 (38.9%)21 (46.7%)
 Hight2 (11.1%)10 (22.2%)

Complete Mexican vaccination scheme.Normal ranges by age and gender: 6 months–<3 years old: male (2.34–5.45 × 103/mcL) and female (2.34–6.44 × 103/mcL); 3–<6 years old: male and female (1.6–5.3 × 103/mcL); 6–<12 years old: male and female (1.4–3.9 × 103/mcL); and ≥12 years old: male and female (1–3.2 × 103/mcL).Normal ranges by age and gender: 6 months–<3 years old: male (7.73–13.12 × 103/mcL) and female (7.05–12.98 × 103/mcL; 3–<6 years old: male and female (4.4–12.9 × 103/mcL); and ≥6 years old: male and female (3.8–10.4 × 103/mcL).Bootstrap value. Significant values are bolded.